CYP2E1 and neoplasm: CYP2E1 C2C2 genotype is significantly associated with advanced clinical stages, and also associated with tumor recurrence, since it is important for determining the parameters associated with tumor progression and poor outcomes in patients with head and neck squamous cell carcinoma [52].